| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196162 Anti-aging and wound healing compounds |
| 03/27/2007 | US7196069 High affinity RNA ligands of basic fibroblast growth factor |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7196063 Peptides and pharmaceutical compositions comprising same |
| 03/27/2007 | US7196059 Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |
| 03/27/2007 | US7196057 pesticides comprising translocating moieties containing plant hemagglutinins capable of acting as carriers to translocate toxins across the ailmentary canal of phytopathogens |
| 03/27/2007 | US7196056 A mixture comprising progenitor cells, are stimulated by exposure to a morphogen, tissue-specific cell differentiation and proliferation; tissue-targeted therapy, promoting liver tissue growth |
| 03/27/2007 | US7196054 Methods for treating wound tissue and forming a supplemented fibrin matrix |
| 03/27/2007 | US7195915 Vectors for animal cells and use thereof |
| 03/27/2007 | US7195896 Complementary adenoviral vector systems and cell lines |
| 03/27/2007 | US7195894 MKK7 activation inhibitor |
| 03/27/2007 | US7195893 Nucleic acids encoding α2δ calcium channel subunits and methods for making and using them |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | US7195879 Method for identifying modulators of NAv ion channels |
| 03/27/2007 | US7195876 Comprises chimeric fusion protein composed of tyrosine kinase domain for diagnosis, prevention and treatment of tumors |
| 03/27/2007 | US7195873 Drug response marker in beta-1 adrenergic receptor gene |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/27/2007 | US7195788 foliage and stems of plant species from the family Rosaceae, genus Prunus, yield natural pesticides when macerated followed by hydrodistillation of the biomass yielding a concentrated solution of organic volatile compounds that act synergistically |
| 03/27/2007 | US7195768 Polyvalent immunogen |
| 03/27/2007 | US7195767 Method to detect IgE |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195763 Treating or preventing infections; polyclonal and monoclonal antibodies |
| 03/27/2007 | US7195762 Density enhanced protein tyrosine phosphatases |
| 03/27/2007 | US7194978 Inducing sterility in fish by disrupting the development of the GnRH system |
| 03/27/2007 | CA2474906C Brassica pyruvate dehydrogenase kinase gene |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2191583C Methods and compositions for modulating morphogenic protein expression |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2133441C Haemophilus somnus immunogenic proteins |
| 03/27/2007 | CA2084552C Novel synthetic isohirudins with improved stability |
| 03/27/2007 | CA1341523C Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav) |
| 03/22/2007 | WO2007033383A2 Process for production of bivalirudin |
| 03/22/2007 | WO2007033140A2 Prok2 antagonists and methods of use |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032523A2 Esterase gene and use thereof |
| 03/22/2007 | WO2007032522A2 Branched-chain amino acid aminotransferase gene and use thereof |
| 03/22/2007 | WO2007032255A1 T-cell receptor and nucleic acid encoding the receptor |
| 03/22/2007 | WO2007032241A1 Microparticle-protein complex, method for production of the complex, semiconductor device, and fluorescent labeling method |
| 03/22/2007 | WO2007032160A1 Marker gene for examining hypertension |
| 03/22/2007 | WO2007031867A2 A hepatitis c virus non-stru tural ns3/4a fusion gene |
| 03/22/2007 | WO2007031741A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 03/22/2007 | WO2007031727A2 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 03/22/2007 | WO2007031608A1 Collagen receptor i-domain binding modulators |
| 03/22/2007 | WO2007031581A2 Plant yield improvement by group 3 lea expression |
| 03/22/2007 | WO2007031572A1 Fish vaccine |
| 03/22/2007 | WO2007031559A2 Human coagulation factor vii polypeptides |
| 03/22/2007 | WO2007031515A1 A material and a method for removing oxo-anions and metal cations from a liquid |
| 03/22/2007 | WO2007031479A1 Method for producing amino acids using micro-organisms |
| 03/22/2007 | WO2007031339A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 03/22/2007 | WO2007031334A2 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 03/22/2007 | WO2007031280A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 03/22/2007 | WO2007031222A2 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | WO2007031187A1 Cleavage of precursors of insulins by a variant of trypsin |
| 03/22/2007 | WO2007031100A1 Active immunotherapy of life-threatening systemic inflammation |
| 03/22/2007 | WO2007031098A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 03/22/2007 | WO2007031081A2 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-Bl00 EXPRESSION |
| 03/22/2007 | WO2007031034A1 Dengue virus capsid protein which induces a protective response and pharmaceutical composition |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | WO2007002493A3 Compositions and methods for modulating the acute phase response |
| 03/22/2007 | WO2006136906A3 Switch-peptides as tool for the study of fibrillogenesis |
| 03/22/2007 | WO2006103421A3 Method for predicting the response to receptor tyrosine kinase inhibitors |
| 03/22/2007 | WO2006096800A3 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 03/22/2007 | WO2006093529A3 Covalent tethering of functional groups to proteins and substrates therefor |
| 03/22/2007 | WO2006076471A3 Bnp conjugates and methods of use |
| 03/22/2007 | WO2006048753A3 Anti-bacterial vaccine compositions |
| 03/22/2007 | US20070067876 Production of Transgenic Poinsettia |
| 03/22/2007 | US20070067874 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 03/22/2007 | US20070067872 Sugar and lipid metabolism regulators in plants III |
| 03/22/2007 | US20070067865 Annotated plant genes |
| 03/22/2007 | US20070067862 Chloroplast transgenic approach to express and purify human serum albumin, a protein highly susceptible to proteolytic degradation |
| 03/22/2007 | US20070067858 Novel il-8-like polypeptides |
| 03/22/2007 | US20070067857 Therapeutic agent for NGF |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070066813 Immunoglobulin fusion comprising blood glycoprotein with reduced glycosylation for use in prevention and treatment of septic shock, cachexia, viral and parasitic infection, autoimmune, arthritic and/or graft rejection |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066811 Adipocyte complement related protein zacrp3x2 |
| 03/22/2007 | US20070066810 Homogeneous preparations of il-28 and il-29 |
| 03/22/2007 | US20070066808 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066807 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066806 Separation methods |
| 03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066802 Chimeric receptors with disrupted dileucine motifs |
| 03/22/2007 | US20070066801 Identification of reagents for the diagnosis and study of francisella |
| 03/22/2007 | US20070066800 Apo2l(trail) receptor binding peptides and uses thereof |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066548 Globin variant gene methods and compositions |
| 03/22/2007 | US20070066538 Treatment of wounds |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066534 Comprising a polypeptide conjugated to one or more lipid moieties; synthetic; highly soluble; contraceptive agent ; vaccine |
| 03/22/2007 | US20070066531 Enhanced membrane binding affinityl blood coagulation |
| 03/22/2007 | US20070066530 Methods for modulating gastric secretion using prokineticin receptor antagonists |